HIV and Latent TB: Opportunities to Optimize Treatment and Decrease Risk for Active TB

Tuberculosis (TB) is one of the leading causes of death among people with HIV globally. According to the latest data from the WHO, the number of deaths in 2022 attributed to TB globally was 1.30 million.¹ People with HIV are also at a higher risk for acquisition of TB and are more likely to become ill compared with HIV-negative individuals. Data from the WHO estimate that individuals with HIV and latent TB are 18 (15-21) times more likely to reactivate TB compared with